Circulating Tumor DNA After Radical Cystectomy as a Marker of Minimal Residual Disease in Muscle-Invasive Bladder Cancer: A Literature Review.
Blood tumor DNA shows promise for detecting early cancer recurrence after bladder removal, though standardization work remains.
This Clin Genitourin Cancer review synthesizes evidence on ctDNA use for minimal residual disease monitoring after radical cystectomy in muscle-invasive bladder cancer. While ctDNA shows promise for early recurrence detection, standardization of assays and protocols remains an important challenge for clinical implementation.
What the study was
- Study design
- Literature review
- Population
- Muscle-invasive bladder cancer patients post-radical cystectomy
- Category
- Early Detection
- Maturity
- Exploratory
- Journal
- Clinical genitourinary cancer
Why it surfaced
Clin Genitourin Cancer review; ctDNA post-cystectomy for MIBC MRD monitoring is clinically relevant surveillance topic.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.